GOLDMAN SACHS GROUP INC - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 37 filers reported holding RANI THERAPEUTICS HLDGS INC in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q1 2023$173,025
+55.9%
33,532
+212.2%
0.00%
Q2 2022$111,000
-69.3%
10,739
-60.0%
0.00%
Q1 2022$362,000
-66.5%
26,820
-55.8%
0.00%
Q3 2021$1,081,00060,6490.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$6,663,0003.16%
LASRY MARC 62,828$848,0000.42%
Alphabet Inc. 714,471$9,645,0000.31%
Alpha Square Group S LLC 101,603$1,372,0000.19%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$6,498,0000.12%
STIFEL FINANCIAL CORP 41,900$566,0000.00%
OSAIC HOLDINGS, INC. 19,343$261,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 71,266$962,0000.00%
STATE STREET CORP 26,142$353,0000.00%
MILLENNIUM MANAGEMENT LLC 32,525$439,0000.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders